NEW YORK, Oct. 22 - DoubleTwist has licensed its Prophecy database, its Prophecy ToolKit, and its Genomatrix Promoter Resource database to pharmaceutical firm Organon, the bioinformatics company said on Monday.
Financial terms of the agreement were not disclosed.
According to DoubleTwist, the Prophecy suite comprises an annotated and assembled human genome database, and data-mining and -visualization tools. The Prophecy ToolKit, meanwhile, allows companies to integrate their in-house sequence data with DoubleTwist's own database, and the GPR database helps researchers locate and characterize genes through polymerase II promoter annotation of the entire human genome.
“We believe this information will help us to identify and verify full-length genes and aid our expression analysis efforts," said Driek Vergouwen, managing director of R&D at West Orange, NJ-based Organon.
Last week, DoubleTwist, based in Oakland, Calif., licensed its Prophecy database and tools suite to GPC Biotech .